Pharma Cold Chain Finance in Europe
Financing for pharmaceutical cold chain projects across Europe — GDP-compliant warehouses, +2/+8°C distribution centers, ULT (-70°C) storage for biologics and mRNA vaccines, and vaccine distribution infrastructure.
A senior cold-chain specialist stays with your project from first brief to commissioning.
Talk to a cold-chain expert on WhatsAppWhy source with ColdMatch
GDP-compliant
+2/+8°C warehouses meeting EU GDP guidelines.
ULT storage
-70°C / -80°C storage for biologics and mRNA.
Distribution centers
Last-mile vaccine and pharma logistics.
Regulatory-aware lenders
Familiar with EMA, MHRA and EU GDP.
Pan-EU coverage
DACH, Benelux, France, Iberia, Italy, Nordics, CEE.
Green finance options
Sustainability-linked lines for low-GWP refrigerants.
Frequently asked
How ColdMatch Group works — independent B2B procurement and sourcing platform — ColdMatch Group is an independent B2B procurement and sourcing platform for industrial refrigeration, cold storage and cold-chain projects from USD $250K+, where the ColdMatch team reviews each buyer brief, contacts suitable third-party suppliers on the buyer's behalf and organizes their responses.
Request a managed sourcing review
Send one request. The ColdMatch team reviews it, contacts suitable manufacturers, EPC contractors and turnkey providers on your behalf and presents organised responses. Free for buyers.
Start Free RFQColdMatch Group is not a lender, bank, financial institution, credit provider, investment advisor or regulated financial services provider. Financing requests submitted through this platform may, subject to user consent, be shared with independent third-party financing providers for evaluation purposes. Any financing approval, terms, pricing, underwriting, due diligence and contractual arrangements are determined solely by the financing provider. Financing is not guaranteed and remains subject to eligibility, compliance checks and lender approval. Neither ColdMatch Group nor its parent, Global B2B Group, provides loans, credit or financial advice; qualified projects may only be introduced to independent financing providers.
Related solutions
ColdMatch Group is not a lender, bank, financial institution, credit provider, investment advisor or regulated financial services provider. Financing requests submitted through this platform may, subject to user consent, be shared with independent third-party financing providers for evaluation purposes. Any financing approval, terms, pricing, underwriting, due diligence and contractual arrangements are determined solely by the financing provider. Financing is not guaranteed and remains subject to eligibility, compliance checks and lender approval. Neither ColdMatch Group nor its parent, Global B2B Group, provides loans, credit or financial advice; qualified projects may only be introduced to independent financing providers.
Take this to a GDP-qualified pharma RFQ
Pharma cold chain projects are judged on qualification and validation, not price alone. Confirm GDP, IQ/OQ/PQ and mapping requirements, then issue a documented RFQ.
Supplier-neutral. Free for buyers and project owners. Best suited to commercial projects from USD $250,000.
Next steps for your project
Wherever your project stands — early feasibility, budget approval or supplier selection — these are the practical next steps. Every stage is supported by our human expert team, and requesting quotes is free and supplier-neutral for buyers and project owners.